Succinylcholine Chloride Injection, Solution
Product Images NDC 70518-4409

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Succinylcholine Chloride (NDC 70518-4409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Succinylcholine Chloride injection, a paralyzing agent used for intravenous or intramuscular administration. It is available in sterile vials with a concentration of 200mg/10mL and should be used with aseptic technique. The medication is manufactured by Somerset Therapeutics LLC and repackaged by RemedyRepack Inc. Facilities for artificial respiration should be readily available as this medication can cause respiratory arrest. Proper storage at 2-8°C is recommended.*

FDA Label Image

Mm2 (Succinylcholine Chloride 200mg 10ml(20mg mL) 70518 4409 01)

This is a description of Succinylcholine Chloride injection, a potent medication that works as a paralyzing agent and can lead to respiratory arrest. The medication is supplied in a sterile 10mL vial with a concentration of 20mg/mL. The dosage and usage instructions are included in the package insert. It is important to have facilities available for artificial respiration in case of emergency. The medication is to be used intravenously or intramuscularly and stored at recommended temperatures. The manufacturer is Somerset Therapeutics LLC, and the repackaging company is RemedyRepack Inc. It is vital to keep this medication out of reach of children.*

FDA Label Image

Structure (E7e7642e Acaa 4907 Aa55 14d509aab194 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.